Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice. - Test2 - elhamkhani - TriplyDB

Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.

Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.

http://www.wikidata.org/entity/Q34394530

about

Antiviral perspectives for chikungunya virus Identifying the Role of E2 Domains on Alphavirus Neutralization and Protective Immune Responses Prime-boost immunization strategies against Chikungunya virus Development of Neutralization Assay Using an eGFP Chikungunya Virus Chikungunya vaccines in development A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis The Global Virus Network: Challenging chikungunya Enterovirus A71 DNA-Launched Infectious Clone as a Robust Reverse Genetic Tool Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera Mosquito-transmitted viruses - the great Brazilian challenge A Review of Chikungunya Virus-induced Arthralgia: Clinical Manifestations, Therapeutics, and Pathogenesis Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.Development of Vaccines for Chikungunya Fever.Animal Models of Chikungunya Virus Infection and Disease.Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations Do we need a vaccine against chikungunya?Versatile Trans-Replication Systems for Chikungunya Virus Allow Functional Analysis and Tagging of Every Replicase Protein.The neutralizing role of IgM during early Chikungunya virus infection Antiviral Phosphorodiamidate Morpholino Oligomers are Protective against Chikungunya Virus Infection on Cell-based and Murine Models Effects of an In-Frame Deletion of the 6k Gene Locus from the Genome of Ross River Virus.Palmitoylation of Sindbis Virus TF Protein Regulates Its Plasma Membrane Localization and Subsequent Incorporation into Virions.Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.Self-replicating alphavirus RNA vaccines.Protective and Pathogenic Responses to Chikungunya Virus Infection.Fc receptors in antibody-dependent enhancement of viral infections.Disentangling the Frames, the State of Research on the Alphavirus 6K and TF Proteins.Differential Phosphatidylinositol-3-Kinase-Akt-mTOR Activation by Semliki Forest and Chikungunya Viruses Is Dependent on nsP3 and Connected to Replication Complex Internalization.DNA-launched live-attenuated vaccines for biodefense applications.Protocols for Developing Novel Chikungunya Virus DNA Vaccines.Chikungunya.Recent progress on chikungunya virus research.Vaccine and Therapeutic Options To Control Chikungunya Virus.Mayaro virus: a neglected arbovirus of the Americas Cellular and Molecular Immune Response to Chikungunya Virus Infection

P2860

Q21284682-C7BF915D-E370-4775-B43A-62FC739D9787 Q24701741-922A6D17-A591-400D-A5C8-D2673909EE92 Q24701774-BF9E963B-69B9-416D-BD8C-DC3FD05310F8 Q26314416-A7F3FC96-5F04-4925-8546-E3AA3EAD9BA7 Q26700081-59B748CA-C687-4A70-B82E-956C0E932377 Q26700129-EA0C635B-7BD6-46A6-880B-681FA9E87324 Q26700155-F1014ED7-1AD6-492F-ADE0-CD64669600C9 Q27468727-CD4DD4A9-AC5C-40D6-820A-9463610E14EC Q27468808-0F883BC9-E579-47ED-B6FD-27818D07D2B0 Q28078140-8DEAFCAC-0D2B-4422-9C7B-F2FD3D42BFB7 Q28353979-8D6ED67F-8DD0-44CE-AAED-DB4CDF530D08 Q30235512-66AE4784-2B63-4C78-A83C-33985B3986AB Q30240191-288F6F9C-5567-4FD4-BB8E-C8C6A06631E9 Q30240216-67D5BC33-C3B4-4D7F-A727-6A8396D7CFF3 Q34593874-605184E6-975C-4740-A116-D0B9CF046731 Q35933249-1D3269A4-DF92-48A9-A105-89183F8BCEE9 Q35952215-CF33BB11-B6F4-48DF-A11D-A35885882DB4 Q36275851-6D9C6D7A-4243-4917-AA4A-4AE31415EF1F Q36292209-97219A14-313F-44E5-A6C2-223D850887BC Q36736422-F56F785B-1AB3-4F97-97CE-0AB64CA55CFA Q37593232-7937070E-55ED-4A91-911F-74DD86BBC1AD Q37711813-BD636D62-1873-4DC3-B2DB-92E5C275BC0C Q38255634-64AAC47D-B940-45EC-A127-E4F394835AB8 Q38586243-44FEB018-3751-4084-99FD-8418378FAE10 Q38615396-AFA0D463-C2B2-4824-B678-BA972D388DB1 Q38618537-F88EBAF1-213A-4935-917B-CD3402F04E9C Q38838063-5DF82FA8-5748-44F2-8326-EB4913196FEF Q40110791-47A4EA61-3508-4B31-B22C-15B8836558C9 Q40656550-768E4471-0987-488C-A28B-7B39DF16F722 Q41838702-CD706E50-16EC-439C-AE03-7F419C06A08B Q44843482-F76A5D50-9F94-436E-B4C2-1F9C1EF84958 Q47566099-DAF432F9-C93E-4718-B9D0-CE593B4E16C8 Q56378882-73F7A9EB-0BEC-40FC-B7A3-E945E392E3FE Q58575620-AF222338-D5F8-4916-857A-229B2C859778

P2860

Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.

http://www.wikidata.org/entity/Q34394530

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Novel attenuated Chikungunya v ...... tive immunity in C57BL/6 mice.

@ast

Novel attenuated Chikungunya v ...... tive immunity in C57BL/6 mice.

@en

Novel attenuated Chikungunya v ...... tive immunity in C57BL/6 mice.

@nl

type

label

Novel attenuated Chikungunya v ...... tive immunity in C57BL/6 mice.

@ast

Novel attenuated Chikungunya v ...... tive immunity in C57BL/6 mice.

@en

Novel attenuated Chikungunya v ...... tive immunity in C57BL/6 mice.

@nl

prefLabel

Novel attenuated Chikungunya v ...... tive immunity in C57BL/6 mice.

@ast

Novel attenuated Chikungunya v ...... tive immunity in C57BL/6 mice.

@en

Novel attenuated Chikungunya v ...... tive immunity in C57BL/6 mice.

@nl

P1433

Q34394530-173E3D51-A361-409A-850F-67673F258ABD

P1476

Q34394530-CE417393-D4F8-4DD0-8B07-6161EE087BC7

P2093

Q34394530-2176FEF1-E196-46DF-8A11-394F87156354

Q34394530-3D857F1F-0A93-4E8B-8398-DD0DC48FA337

Q34394530-7A6991FE-30F6-4238-94B4-1C5D03F8207A

Q34394530-A2C878D1-12AA-4A21-A30C-4742E813D817

Q34394530-D5D43495-BE3D-4CAF-BE49-269C0F840C81

P2860

Q34394530-060205DC-BD47-4796-A69E-83B282D02655

Q34394530-0FD08EB2-CD27-40F1-BFAD-757D058D1A14

Q34394530-1E22E4D7-0673-48C8-8D95-911F17E78FC5

Q34394530-29266E9E-94A7-406E-8621-57FAE13EDBA7

Q34394530-2A99CC0F-3748-4A6A-99F0-E6EF1A32473E

Q34394530-32840A7F-ED3E-4B38-9037-3C291FD9B0D3

Q34394530-334DB946-A37D-487E-B727-71161D88591A

Q34394530-353E9B6E-BD1F-420C-97D2-30FF199C7C97

Q34394530-36DF2269-DD31-4432-B2DD-A30FA615A1C1

Q34394530-3E691657-021B-4CAC-B203-5E1A568A5F3E

P304

Q34394530-96940691-5CDE-4A14-8F0A-9CF171D9BBCF

P31

Q34394530-4A2C44A6-23F7-4E6E-BBC1-60DEBB6A9B74

P356

Q34394530-7BB8AFC0-8D00-47F2-AFEB-AD08049BF8F7

P407

Q34394530-70857A70-C6E3-4C83-BE8B-35EF629EF61A

P433

Q34394530-604B75DB-3EF7-4645-A334-E04399E08245

P478

Q34394530-B8B99E02-760A-45EE-AEC5-AA4B3BC65AB9

P50

Q34394530-258C8078-C366-46AE-8994-9645BA74C51E

Q34394530-371F3BB6-4308-4553-BEF2-1E5EEC87D3E2

Q34394530-50EE6615-D47E-4280-8027-F09315F28F51

Q34394530-5680E8BE-609A-4DD2-BD4E-EE04EFD73C46

Q34394530-A2C29ECF-D94B-4007-8FD6-4A5604341A7D

Q34394530-AB120E82-0656-4A4E-B8F2-3EC20C85190C

Q34394530-E7CD23EC-F387-4D1C-A128-18F382CC4530

P5008

Q34394530-B8FA75BB-BB45-4187-8D24-83CCD31BF7A0

P577

Q34394530-3F840123-0490-4B00-9FF7-7EEB011D6A6B

P698

Q34394530-CB8887EE-30D6-4B49-A3AD-42395FF60699

P921

Q34394530-069F2892-2C27-48B1-978D-C747D81F3B1B

Q34394530-AB9AF685-5CD5-4B22-B9ED-E15115471DAA

P932

Q34394530-9A48E46F-A2A4-4F9B-A6E3-1FD5E37860F5

P356

P1433

Journal of Virology

P1476

Novel attenuated Chikungunya v ...... tive immunity in C57BL/6 mice.

@en

P2093

Daniel X Johansson

http://www.w3.org/2001/XMLSchema#string

Margit Mutso

http://www.w3.org/2001/XMLSchema#string

Maria Kakoulidou

http://www.w3.org/2001/XMLSchema#string

Peter Liljeström

http://www.w3.org/2001/XMLSchema#string

Roger Le Grand

http://www.w3.org/2001/XMLSchema#string

P2860

A single mutation in chikungunya virus affects vector specificity and epidemic potential

Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak

Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release

Increased Mortality Rate Associated with Chikungunya Epidemic, Ahmedabad, India

Chimeric alphavirus vaccine candidates for chikungunya

Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus

P304

2858-2866

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.03453-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

John Fazakerley

Beate M. Kümmerer

David Hallengärd

P5008

P577

2013-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24371047

http://www.w3.org/2001/XMLSchema#string

P921

Chikungunya virus

attenuated vaccine

P932

3958085

http://www.w3.org/2001/XMLSchema#string